Follow us on Twitter
twitter icon@FreshPatents


Pension patents

      

This page is updated frequently with new Pension-related patent applications.




 Ibuprofen for topical administration patent thumbnailIbuprofen for topical administration
Set forth herein is a preparation of ibuprofen (2-(4-isobutylphenyl) propionic acid) in the free acid form that is suitable for topical administration. The topical ibuprofen formulation is prepared by dissolving the free acid form of ibuprofen, or preparing a homogeneous suspension of the free acid form of ibuprofen, in the presence of a pharmaceutically acceptable solvent so as to produce a topical drug formulation compatible with the penetration of 2-(4-isobutylphenyl) propionic acid through the skin tissue.
Biochemics, Inc.


 Devices, formulations, and methods for delivery of multiple beneficial agents patent thumbnailDevices, formulations, and methods for delivery of multiple beneficial agents
The present invention relates to osmotic delivery devices, formulations, and methods for delivery of two or more beneficial agents. In one aspect, the present invention provides osmotic delivery devices useful for substantially concurrent administration of two or more beneficial agents.
Intarcia Therapeutics Inc.


 Osmotic delivery device comprising an insulinotropic peptide and uses thereof patent thumbnailOsmotic delivery device comprising an insulinotropic peptide and uses thereof
A suspension formulation of an insulinotropic peptide (e.g., glucagon-like peptide-1 (glp-1) or exenatide) is described. The suspension formulation comprises (i) a non-aqueous, single-phase vehicle, comprising one or more polymer and one or more one solvent, wherein the vehicle exhibits viscous fluid characteristics, and (ii) a particle formulation comprising the insulinotropic peptide, wherein the peptide is dispersed in the vehicle.
Intarcia Therapeutics, Inc.


 Methods for producing an oralsuspension of teichoplanin or teichoplanin analogs patent thumbnailMethods for producing an oralsuspension of teichoplanin or teichoplanin analogs
A stable suspension of teicoplanin and one or more pharmaceutically acceptable additives and method for preparation wherein the teicoplanin is mixed with an aqueous or non aqueous suspension base and pharmaceutically acceptable additives and wherein the teicoplanin is milled to obtain a homogeneously dispersed suspension.. .

 Pharmaceutical suspension composition patent thumbnailPharmaceutical suspension composition
An aqueous oral liquid pharmaceutical composition system with reduced propensity for agglomeration and phase separation which is particularly amendable to the suspension of one or more pharmaceutical actives that are substantially insoluble in water. The oral liquid pharmaceutical composition may further comprise pharmaceutical actives that are soluble in water and dissolve in the aqueous medium.
Wyeth Llc


 Solvent/polymer solutions as suspension vehicles patent thumbnailSolvent/polymer solutions as suspension vehicles
A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment.
Intarcia Therapeutics Inc.


 Synthesis, capping and dispersion of nanocrystals patent thumbnailSynthesis, capping and dispersion of nanocrystals
Preparation of semiconductor nanocrystals and their dispersions in solvents and other media is described. The nanocrystals described herein have small (1-10 nm) particle size with minimal aggregation and can be synthesized with high yield.
Pixelligent Technologies, Llc


 Method for making bismuth containing liquid pharmaceutical suspensions patent thumbnailMethod for making bismuth containing liquid pharmaceutical suspensions
A method of producing a liquid pharmaceutical suspension by mixing magnesium aluminum silicate, gellan gum, bismuth subsalicylate, and methyl cellulose.. .
The Procter & Gamble Company


 Suspension concentrate patent thumbnailSuspension concentrate
An aqueous suspension concentrate containing: (a) a first active ingredient comprising one or more triazolopyrimidine, triazolone, pyrazole or oxazole herbicides; (b) optionally, a second active ingredient, (c) a dispersant comprising a comb polymer; (d) a nonionic, alkoxylated surfactant or a block copolymer surfactant, and (e) optionally, a re-dispersing agent, wherein said aqueous suspension concentrate exhibits an acidic ph within the range from about greater than about 2 to about 4.. .

 Bismuth containing liquid pharmaceutical suspensions patent thumbnailBismuth containing liquid pharmaceutical suspensions
A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate..
The Procter & Gamble Company


Micronutrient compositions

An agrochemical micronutrient concentrate and or formulations with dispersants for said concentrates/formulations, in particular a dispersant for use in suspending solid micronutrients in suspension concentrate type formulations comprising one or more micronutrients. The dispersant is preferably a water dispersible styrene (meth)acrylic copolymer.
Croda International Plc

Electronically controlled suspension system, controlling a suspension system and computer program

A seat post for a bicycle comprises a post body having a first end shaped to be connected to a bicycle frame, a second end shaped to be connected to a saddle, at least two longitudinal portions meshing with each other and slidable relative to one another along a longitudinal extension, and a fixing apparatus by which the two longitudinal portions can be fixed to one another in a settable relative position, the fixing apparatus being influenced to selectively fix and unfix by a radio signal.. .
Gustav Magenwirth Gmbh & Co. Kg

Stable suspension of a steviol glycoside in concentrated syrup

A method is provided for preparation of a syrup or concentrate containing one or more stable suspensions of steviol glycosides comprising the steps of: adding one or more steviol glycosides to an aqueous solution to provide a steviol mixture; adjusting the ph of the steviol mixture at ambient temperatures to a ph in a range of about 7-9; then again adjusting the ph of the steviol mixture, with a sufficient amount of an acidic aqueous solution, to a ph in a range of about 2-4 to provide a liquid beverage concentrate containing a stable suspension of one or more solid steviol glycoside particles having a size of about 10-80 um long and 0.1-2 um thick, and having a concentration of up to about 1000-3000 ppm. Syrup or concentrate compositions are also provided..
Cargill, Incorporated

Homogenous suspension of immunopotentiating compounds and uses thereof

The present invention generally relates to homogeneous suspensions of small molecule immune potentiators (smips) that are capable of stimulating or modulating an immune response in a subject in need thereof. The homogeneous suspensions may be used in combinations with various antigens or adjuvants for vaccine therapies..
Glaxosmithkline Biologicals Sa

Nanoparticle isoflavone compositions & methods of making and using the same

The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein..
Humanetics Corporation

Method for preparing a suspension containing carbon nanotubes and stable suspension obtained in this way

The present invention concerns a method for preparing a suspension of carbon nanotubes in an aqueous solution comprising the following successive steps consisting of subjecting an aqueous solution containing carbon nanotubes and a surfactant to at least one cycle of freezing in liquid nitrogen and thawing; and subjecting said thawed solution to an ultrasound treatment. The present invention also concerns a suspension of carbon nanotubes, and in particular a suspension of long carbon nanotubes, that can be prepared by such a method..
Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives

Method of treating middle ear infections

Aqueous suspension formulations containing dexamethasone and ciprofloxacin are disclosed for the treatment of middle ear infections in human patients having an open tympanic membrane.. .
Alcon Pharmaceuticals Ltd

Nanosuspension of natural materials and preparation method thereof

The present disclosure relates to a method for the preparation of a nanosuspension of at least one natural material, wherein the method comprises the steps of (a) providing at least one natural material having a particle size (d90) of less than 320 μm; (b) dispersing said at least one natural material of step (a) in a solvent; and (c) milling the dispersion of step (b) to a particle size (d90) of below 1000 nm. The nanosuspension is useful for the preparation of a medicament..
Apurano Pharmaceuticals Gmbh

Pediatric oral suspension formulations of amoxicillin and clavulanate potassium and using same

The invention is directed to a pediatric oral suspension composition containing amoxicillin and clavulanate potassium where the clavulanate potassium is present in an amount equal to or less than about 21.5 mg/5 ml, and a method of treating bacterial infections by providing between about one to about fourteen dosage days of the composition.. .

Concentrated suspension of agrochemicals in high electrolyte aqueous medium

The present invention generally relates to stable suspension concentrates (sc) displaying shear thinning property and comprising: a water soluble salt, an electrolyte water thickening polymer (eg. Xanthan gum or guar gum), an insoluble solid agrochemical and water.
Akzo Nobel Chemicals International B.v.

Pymetrozine suspension concentrates and its preparation method

The present disclosure relates generally to insecticide formulations. The present disclosure relates more particularly to aqueous pymetrozine formulations that can be provided in concentrate form and methods for making them.
Dow Global Technologies Llc

Special modified expandable polystyrene copolymer particle for lost foam and production method therefor

The present invention discloses a special modified expandable polystyrene copolymer particle for a lost foam, which respectively comprises the following parts by weight: 90 to 100 parts of styrene; 3 to 8 parts of methyl methacrylate; 100 to 140 parts of deionized water; 0.2 to 0.5 part of benzoyl peroxide; 0.2 to 0.5 part of dicumyl peroxide: 0.1 to 0.5 part of tert-butyl peroxybenzoate: 0.001 to 0.01 part of anionic surfactant; 1 to 2 parts of suspension concentrate; 5.0 to 10.0 parts of foaming agent; 0.1 to 0.4 part of nucleator; 0.2 to 2 parts of organic bromine; 0.01 to 0.1 part of molecular weight regulator having the effect of increasing molecular weight, and 0.3 to 0.5 part of surface coating agent. The special modified expandable polystyrene copolymer particle for the lost foam and a production method therefor of the present invention effectively solve the existing problem of no special eps for lost foam casting, and have the advantages of reducing the generation of a carbon defect problem during foundry of a casting and increasing the molecular weight..
Zhejiang Castchem New Material Co.,ltd

Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative

The present invention relates to a suspension formulation containing the active substance 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl -methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate, to a capsule pharmaceutical dosage form containing said suspension formulation, to a process for preparing said suspension formulation, to a process for preparing said capsule comprising said suspension formulation and to the packaging material for the finished capsule.. .
Boehringer Ingelheim International Gmbh

Freeze dried drug nanosuspensions

The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an acceptable stability of the particle size distribution during storage, including long term storage..
Janssen Pharmaceutical Nv

Additive package compositions for pesticide suspension concentrate formulations

The present invention provides compositions containing a wetting agent, a polycarboxylate type surfactant, and a sulfonate type surfactant. The composition can be used as an additive package composition in a pesticide suspension concentrate formulation to enhance thermal stability..
Dow Global Technologies Llc

Apparatus, a dispensing system of a refrigerated appliance

An apparatus, method and system for sensing parameters related to water and/or ice being dispensed from a dispensing station of a refrigerated appliance is disclosed. The dispensing system includes a sensing system positionable at the dispensing station at the point of dispension for liquid and/or ice to sense a parameter related to dispensed water and/or ice and produce a sensing signal..
Whirlpool Corporation

Aerosol formulations comprising formoterol fumarate dihydrate

The invention provides a method of producing a highly stable pharmaceutical aerosol suspension formulation suitable for use in a metered dose inhaler, the formulation comprising formoterol fumarate di-hydrate in suspension, a steroid in suspension, a propellant and ethanol, the method comprising the steps of drying the formoterol fumarate di-hydrate to a water content of 4.8 to 4.28%.. .
Jagotec Ag

Pumpable shelf-stable suspension of fibers in an organic phase

A pumpable shelf-stable suspension of fibers in an organic phase comprising 1.0-60 wt % of fibers and 0.01-10 wt % of a disubstituted urea is proposed as well as a method using the disubstituted urea to suspend fibers in an organic phase.. .
Basf Se

An improved process for manufacturing sterile ophthalmic pharmaceutical suspensions

The present invention provides a process of manufacturing a sterile, ophthalmic pharmaceutical suspension comprising sterile active ingredient(s) such as sterile carbonic anhydrase inhibitors (cais) wherein the process does not involve the use of any special equipment's such as ball mill, milling bottle and/or jet mill the present process is simple, cost effective and efficient.. .
Sentiss Pharma Private Limited

Suspension compositions of physiologically active phenolic compounds & methods of making and using the same

The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular embodiments, the compositions described herein include suspension formulations including a physiologically active phenolic compound provided as a nanoparticulate material and dispersed within an edible lipid..
Humanetics Corporation

Concentrated natamycin suspension formulations

The present invention generally relates to concentrated natamycin suspension formulations for inhibition of fungal growth. Specifically, the present invention relates to stable suspension concentrate formulations comprising from about 25% to about 48% w/w natamycin, from about 0.1% to about 10% w/w of an anionic surfactant selected from the group consisting of polyelectrolyte polymers, modified styrene acrylic polymers, dioctyl sodium sulfosuccinates, sodium salts of naphthalene sulfonates, and combinations thereof, and water.
Valent Biosciences Corporation

Adaptive mouth guard and use

A dental appliance is disclosed designed to protect a wearer's dentitions against injury from impacts suffered in sports or other activities that can cause chipping, fracturing, dislodging or evulsion of teeth. The appliance may be custom-fittable with at least one pocket having an energy absorbing fluid.
Akervall Technologies, Inc.

Fluid cartridge and dispension device

An arrangement for dispensing a fluid comprises a fluid cartridge comprising a casing for accommodating the fluid and a fluid dispensing unit configured for generating particles upon feeding the fluid in the casing with pressurized medium. The arrangement further comprises a dispenser device comprising a cartridge accommodation unit configured for accommodating the fluid cartridge and a pressure feed unit configured for feeding the fluid in a casing of the fluid cartridge with a pressurized medium upon accommodating the fluid cartridge in the cartridge accommodation unit to thereby generate the particles upon feeding the fluid in the casing with the pressurized medium..
Medic Activ Vertriebs Gmbh

Method of treating middle ear infections

Aqueous suspension formulations containing dexamethasone and ciprofloxacin are disclosed for the treatment of middle ear infections in human patients having an open tympanic membrane.. .
Alcon Pharmaceuticals Ltd.

Cellulose suspension, the production and use thereof

The present invention relates to a phase-stable suspension of cellulose ii in water, having a high water retention capacity and a cellulose concentration between 0.1 and 5.0% by weight, a method of its preparation, and its use.. .
Lenzing Ag

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne.
Dow Pharmaceutical Sciences, Inc.

Ocular formulations for drug-delivery and protection of the anterior segment of the eye

Or its free base, and a second active agent selected from nicotinic acid, nicotinamide, and vitamin k, and a combination thereof, for treating ocular neovascularization. The present application also relates to pharmaceutical compositions comprising particles of compound-i or its free base, and suspension formulations comprising the particle compositions of compound-i or its free base..

Novel drug formulation

There is provided inter alia a pharmaceutical aqueous nanosuspension comprising (i) 4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluorobenzamide in nanoparticulate form and a stabilizing agent.. .
Fab Pharma Sas

Synthesis, capping and dispersion of nanocrystals

Preparation of semiconductor nanocrystals and their dispersions in solvents and other media is described. The nanocrystals described herein have small (1-10 nm) particle size with minimal aggregation and can be synthesized with high yield.
Pixelligent Technologies, Llc

Electric-drive all-terrain utility vehicle

The invention is an all-terrain utility vehicle comprising: a support chassis frame; four wheels removably attached to respective adjustable suspension components that are removably attached to the support chassis frame; a transfer case, an electric motor, and an engine mounted on the support chassis frame; removable personnel seats; and a battery mounted on the support chassis frame.. .

High-concentration monoclonal antibody formulations

The present application discloses high-concentration monoclonal antibody formulations suitable for subcutaneous administration, e.g. Via a pre-filled syringe.

Devices and methods for the controlled formation and dispension of small drops of highly viscous and/or non-newtonian liquids

The disclosed spray deposition systems and methods control the formation and dispensation of droplets during the atomization of a fluid. Such systems and methods generally can generate small quantities and droplets of a desired size of highly-viscous fluids and/or fluids having non-newtonian properties or other complex rheologies using mechanical systems and processes with the option of further controlling the droplet size and/or the volume of droplets with various enhancements.

Pharmaceutical composition comprising brinzolamide

The present invention provides an improved novel process of manufacturing a sterile, ophthalmic pharmaceutical suspension comprising an active ingredient(s) such as carbonic anhydrase inhibitors (cais) wherein the said process involves solubilization, followed by controlled precipitation of carbonic anhydrase inhibitors of the right particle size, e.g., less than 10 micron, preferably less than 5 micron (d90) by varying ph with a little or no homogenization. Said process further does not require the use of any special equipment such as ball mill, milling bottle and/or jet mill.

Nanoparticle isoflavone compositions & methods of making and using the same

The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein..

A dynamically adjustable suspension device

The present invention discloses a dynamically adjustable suspension device including one or more springs having similar or different spring rates, where said one or more springs are arranged in a pre-defined configuration, and a dynamically adjustable damper. The dynamically adjustable damper, includes a rotatable knob coupled to the dynamically adjustable damper to change the damping coefficient dynamically in real-time, means to rotate the knob so as to adjust damping coefficient in real-time while the dynamically adjustable suspension device being used, means to identify compression of the one or more springs by sensing one or more positions of the springs, between a fully elongated state and a fully compressed state in real-time..
Kpit Cummings Infosystems Limited

Methods and treatment for certain demyelination and dysmyelination-based disorders and/or promoting remyelination

The invention relates to methods and compositions for treating demyelination and/or dysmyelination and/or promoting remyelination of neurons and/or preventing the development of myelin-related diseases by administering to a subject in need thereof an effective amount (either therapeutic or prophylactic) of an elemental gold crystal nanosuspension.. .
Gr Intellectual Reserve, Llc

Prosthetic socket suspension device embodiments

Embodiments of the technology include a prosthetic socket suspension device having a distal cup portion and a liner garment portion, these two portions being bonded together. In various embodiments, a distal cup may be disposed within a liner, a liner may be disposed within a distal cup, and a distal cup may be disposed between distally bifurcated internal and an external layers of a liner.
Lim Innovations, Inc.

Suspension concentrate composition comprising isothiazoline insecticide and activated charcoal

Subject matter of the present invention is a suspension concentrate composition comprising an a) isothiazoline insecticide and b) activated charcoal, wherein the composition is substantially free of a non-polar solvent. The invention further relates to a process for the preparation of said composition; a suspension obtainable by mixing water, an isothiazoline insecticide and activated charcoal; and to a method for controlling undesired attack by insects or mites, where the suspension concentrate composition or the suspension is allowed to act on the respective pests, their environment or on the crop plants to be protected from the respective pests..
Basf Se





Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Pension for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pension with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.798

file did exist - 2854

2 - 1 - 51